Полиморфизмы
НП «ЦПИ» на договорной основе проводит измерения полиморфизмов по программе генетической паспортизации. Полиморфизмы анализируются методом MALDI-TOF масс-спектрометрии.
По вопросам заключения договоров обращаться к директору НП «ЦПИ» Бодоеву Николаю Васильевичу: тел. +7 499 135-25-58, E-mail: nbod@rambler.ru
|
№ |
Name |
Gene |
Polymorphism |
Стоимость одного определения,руб. |
|
1 |
Prothrombin (F II) |
FII |
G20210A |
90 |
|
2 |
Leiden factor |
FV |
G1691A |
90 |
|
3 |
Fibrinogen |
FGB |
G 455A |
90 |
|
4 |
Methylenetetrahydrofolate reductase |
MTHFR |
С677T |
90 |
|
5 |
Integrin beta3 |
ITGB3 (GPIIIA) |
C (-1565)T |
90 |
|
6 |
Integrin beta3 |
ITGB3 (GPIIIA) |
T98C |
90 |
|
7 |
plasminogen activator inhibitor-1 |
PAI I |
1bp D/I, 4G/5G] |
90 |
|
8 |
Factor VII |
F VII |
R353Q |
90 |
|
9 |
Interleikin 1 beta |
IL1B |
3953 |
90 |
|
10 |
Interleikin 1 beta |
IL1B |
511 |
90 |
|
11 |
Interleikin 1 beta |
IL1B |
31 |
90 |
|
12 |
Interleikin 1 alpha |
IL1A |
889 |
90 |
|
13 |
Interleikin 1 alpha |
IL1A |
4845 |
90 |
|
14 |
Interleikin 6 |
IL6 |
564 |
90 |
|
15 |
Interleikin 6 |
IL6 |
172 |
90 |
|
16 |
Interleikin 6 |
IL6 |
Pro8/9/10A |
90 |
|
17 |
Tumor necrosis factor alpha |
TNFA |
308 |
90 |
|
18 |
Tumor necrosis factor alpha |
TNFA |
863 |
90 |
|
19 |
Cystic fibrosis transmembrane conductance regulator |
CFTR |
del508 |
90 |
|
20 |
Cystic fibrosis transmembrane conductance regulator |
CFTR |
F508C |
90 |
|
21 |
Cystic fibrosis transmembrane conductance regulator |
CFTR |
IVS8SA-5T |
90 |
|
22 |
Collagen type I |
COLA-1A |
2046 |
90 |
|
23 |
adrenergic receptor |
ADRB1 |
145 |
90 |
|
24 |
adrenergic receptor |
ADRB1 |
1165 |
90 |
|
25 |
Apolipoprotein E |
ApoE |
2/3/4
|
90 |
|
26 |
Alpha-2-macroglobulin |
A2M |
Exon 18 del |
90 |
|
27 |
Hemochromatosis |
HFE |
63 |
90 |
|
28 |
Hemochromatosis |
HFE |
65 |
90 |
|
29 |
Hemochromatosis |
HFE |
282 |
90 |
|
30 |
adenomatous polyposis coli |
APC |
del |
90 |
|
31 |
C-C chemokine receptor 5 |
CCR5 |
del32 |
90 |
|
32 |
C-C chemokine receptor 5 |
CCR5 |
-502 |
90 |
|
33 |
C-C chemokine receptor 5 |
CCR5 |
m303 |
90 |
|
34 |
C-C chemokine receptor 5 |
CCR |
2-64 |
90 |
|
35 |
SPDF1 |
SDF1 |
-3‘A |
90 |
|
36 |
Apolipoprotein С3 |
АРОС3 |
C1100T |
90 |
|
37 |
Apolipoprotein С3 |
APOC3 |
C -482T |
90 |
|
38 |
Apolipoprotein E |
APOE |
90 | |
|
39 |
Apolipoprotein E |
APOE |
90 | |
|
40 |
Apolipoprptein B |
ApoB |
C2488T |
90 |
|
41 |
Apolipoprptein B |
ApoB |
G4154A |
90 |
|
42 |
Apolipoprotein(a) |
LPA |
C93T |
90 |
|
43 |
Apolipoprotein(a) |
LPA |
G121A |
90 |
|
44 |
Lipoprotein lipase |
LPL |
C1595G |
90 |
|
45 |
Lipoprotein lipase |
LPL |
G281A |
90 |
|
46 |
Hepatic lipase |
LIPC |
C(-514)T |
90 |
|
47 |
Hepatic lipase |
LIPC |
C(-2)T |
90 |
|
48 |
Hepatic lipase |
LIPC |
A884G |
90 |
|
49 |
ABCA1 transporter |
ABCA1 |
R-219-K |
90 |
|
50 |
ABCA1 transporter |
ABCA1 |
Ile823Met |
90 |
|
51 |
Lipoprotein receptor-related protein 1 |
LRP1 |
C200T |
90 |
|
52 |
Lipoprotein receptor-related protein 1 |
LRP1 |
C663T |
90 |
|
53 |
Lipoprotein receptor-related protein 1 |
LRP1 |
C766T |
90 |
|
54 |
Lectin-like oxidazed LDL receptor |
LOX-1/OLR1 |
C(-25)G |
90 |
|
55 |
Lectin-like oxidazed LDL receptor |
LOX-1/OLR1 |
G501C |
90 |
|
56 |
Angiotensinogen |
AGT |
T174M |
90 |
|
57 |
Angiotensinogen |
AGT |
M235T |
90 |
|
58 |
Angiotensin I-converting enzyme |
АСЕ |
Alu I/D |
90 |
|
59 |
Angiotensin receptor I |
AGTR1 |
A1166C |
90 |
|
60 |
nitric oxide synthase |
NOS |
E298D |
90 |
|
61 |
Paraoxonase |
PON I |
С (-108) Т |
90 |
|
62 |
endothelin receptor |
EDNR |
C969T |
90 |
|
63 |
Serotonin receptor 2A |
HTR2A |
Т102С |
90 |
|
64 |
Peroxisome proliferator activated receptor A |
PPARA |
K162V |
90 |
|
65 |
Peroxisome proliferator activated receptor G |
PPARG |
P12A |
90 |
|
66 |
Cytochrome P450 |
CYP2C9 |
R144C |
90 |
|
67 |
Cytochrome P450 |
CYP2C9 |
L208V |
90 |
|
68 |
Cytochrome P450 |
CYP1A2 |
-2964(G/A) |
90 |
|
69 |
Cytochrome P450 |
CYP1A2 |
-164A-->C |
90 |
|
70 |
Cytochrome P450 |
CYP1A2 |
2464T-->delT |
90 |
|
71 |
Cytochrome P450 |
CYP1A2 |
3858G-->A |
90 |
|
72 |
Cytochrome P450 |
CYP2C19 |
CYP2C19*2 (40bp del) |
90 |
|
73 |
Cytochrome P450 |
CYP2C19 |
CYP2C19*5 R433W |
90 |
|
74 |
Cytochrome P450 |
CYP2C19 |
CYP2C19*3 |
90 |
|
75 |
Cytochrome P450 |
CYP2D6 |
R296C |
90 |
|
76 |
Cytochrome P450 |
CYP2D6 |
G42R |
90 |
|
77 |
Cytochrome P450 |
CYP2D6 |
P34S |
90 |
|
78 |
Cytochrome P450 |
CYP2D6 |
G169Stop |
90 |
|
79 |
Cytochrome P450 |
CYP2E1 |
G1293T |
90 |
|
80 |
Alcohol dehydrogenase-2 |
ADH2 |
ADH2*2 R47H |
90 |
|
81 |
Aldehyde dehydrogenase-2 |
ALDH2 |
G487K |
90 |
|
82 |
Cytochrome P450 |
CYP3A4 |
CYP3A4*1B A392G |
90 |
|
83 |
CYP3A5 |
CYP3A5*3 |
90 | |
|
84 |
Breast cancer gene 1 |
BRCA1 |
5382insC |
90 |
|
85 |
Breast cancer gene 1 |
BRCA1 |
4153delA |
90 |
|
86 |
Breast cancer gene 1 |
BRCA1 |
G181T |
90 |
|
87 |
Breast cancer gene 2 |
BRCA2 |
S1099X |
90 |
|
88 |
Breast cancer gene 2 |
BRCA2 |
1528delAAAA |
90 |
|
89 |
Breast cancer gene 2 |
BRCA2 |
9318delAAAA |
90 |
|
90 |
Tumor protein p53 |
TP53 |
C215G |
90 |
|
91 |
Tumor protein p53 |
TP53 |
IVS3-16bpI/D |
90 |
|
92 |
Tumor protein p53 |
TP53 |
IVS6-AluI/D |
90 |
|
93 |
Cell-cycle checkpointkinase |
CHEK2 |
1100delC |
90 |
|
94 |
Glucocorticoid receptor |
NR3C1 |
A1220G |
90 |
|
95 |
Matrix metalloproteinase-9 |
MMP-9 |
C(-1562)T |
90 |
|
96 |
Glucose transporter 2 |
SLC2A2 |
IVS5-15 C/T |
90 |
|
97 |
Glucose transporter 2 |
SLC2A2 |
G592T |
90 |
|
98 |
Glucose transporter 2 |
SLC2A2 |
C3307T |
90 |
|
99 |
Sulfonylurea receptor |
ABCC8 |
IVS38+54 C/G |
90 |
|
100 |
Sulfonylurea receptor |
ABCC8 |
IVS18-36 C/T |
90 |
|
101 |
Sulfonylurea receptor |
ABCC8 |
G1948A |
90 |
|
102 |
Sulfonylurea receptor |
ABCC8 |
IVS11-74 G/A |
90 |
